"Data on preclinical and clinical studies will be published in the coming days, possibly by Monday," TASS reported.
The minister noted that criticism of the new Russian vaccine was largely due to the fact "that more data had to be obtained on research," adding that not everyone knows that "the vaccine is based on a platform, on which six products have already been made." He assured that clinical trials would continue.
